Report

You have full text access to this OnlineOpen article

Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC

  1. Oscar Rubio-Cabezas1,14,15,†,
  2. Vishwajeet Puri2,†,
  3. Incoronata Murano3,
  4. Vladimir Saudek4,
  5. Robert K. Semple4,
  6. Satya Dash4,
  7. Caroline S. S. Hyden4,
  8. William Bottomley5,
  9. Corinne Vigouroux6,7,8,
  10. Jocelyne Magré6,7,
  11. Philippa Raymond-Barker9,
  12. Peter R. Murgatroyd9,
  13. Anil Chawla2,
  14. Jeremy N. Skepper10,
  15. V. Krishna Chatterjee4,
  16. Sara Suliman11,
  17. Ann-Marie Patch12,
  18. Anil K. Agarwal13,
  19. Abhimanyu Garg13,
  20. Inês Barroso5,
  21. Saverio Cinti3,
  22. Michael P. Czech2,
  23. Jesús Argente1,14,15,
  24. Stephen O'Rahilly4,
  25. David B. Savage4,*

Article first published online: 5 AUG 2009

DOI: 10.1002/emmm.200900037

Issue

EMBO Molecular Medicine

EMBO Molecular Medicine

Volume 1, Issue 5, pages 280–287, August 2009

Additional Information

How to Cite

Rubio-Cabezas, O., Puri, V., Murano, I., Saudek, V., Semple, R. K., Dash, S., Hyden, C. S. S., Bottomley, W., Vigouroux, C., Magré, J., Raymond-Barker, P., Murgatroyd, P. R., Chawla, A., Skepper, J. N., Chatterjee, V. K., Suliman, S., Patch, A.-M., Agarwal, A. K., Garg, A., Barroso, I., Cinti, S., Czech, M. P., Argente, J., O'Rahilly, S. and Savage, D. B. (2009), Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC. EMBO Mol Med, 1: 280–287. doi: 10.1002/emmm.200900037

Author Information

  1. 1

    Department of Endocrinology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain

  2. 2

    Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA

  3. 3

    Institute of Normal Human Morphology, University of Ancona, Ancona, Italy

  4. 4

    Metabolic Research Laboratories, Institute of Metabolic Science, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK

  5. 5

    Metabolic Disease Group, The Wellcome Trust Sanger Institute, Hinxton, UK

  6. 6

    UPMC Univ Paris 06, UMR_S938, Paris, France

  7. 7

    INSERM, UMR_S938, Faculté de Médecine Pierre et Marie Curie, Site Saint-Antoine, Paris, France

  8. 8

    AP-HP, Hôpital Tenon, Service de Biochimie et Hormonologie, Paris, France

  9. 9

    Wellcome Trust Clinical Research Facility, Addenbrooke's Hospital, Cambridge, UK

  10. 10

    Multi-imaging Centre, Physiology Development & Neuroscience, University of Cambridge, Cambridge, UK

  11. 11

    Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), University of Oxford, Oxford, UK

  12. 12

    Institute of Biomedical and Clinical Science (AM.P.), Peninsula Medical School, Exeter, UK

  13. 13

    Division of Nutrition and Metabolic Diseases, Department of Internal Medicine, Center for Human Nutrition, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA

  14. 14

    Department of Pediatrics, Universidad Autónoma de Madrid; Madrid, Spain

  15. 15

    CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain

  1. †

    These authors contributed equally to this work.

*Tel: +44 1223 767923; Fax: +44 1223 330598

Publication History

  1. Issue published online: 5 AUG 2009
  2. Article first published online: 5 AUG 2009
  3. Manuscript Accepted: 2 JUL 2009
  4. Manuscript Revised: 29 JUN 2009
  5. Manuscript Received: 14 APR 2009

Funded by

  • Wellcome Trust (R.K.S., V.K.K.C., S.O'R., D.B.S., W.B., I.B.(WT)). Grant Number: 077016/Z/05/Z
  • CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN) from the ‘Instituto de Salud Carlos III’
  • Fundación Endocrinología y Nutrición, Madrid, Spain (J.A.)
  • GlaxoSmithKline (D.B.S.)
  • U.K. NIHR Cambridge Biomedical Research Centre
  • National Institutes of Health. Grant Numbers: DK30898, DK60837, DK54387
  • Biomedical Imaging Core Facility of the University of Massachusetts Diabetes and Endocrinology Center (National Institutes of Health). Grant Number: DK32520
  • Diabetes UK (S.S.)
  • Italian Ministry of University. Grant Number: FIRB RBIN047PZY_000
  • Cofin. PRIN bando 2007
  • Aide aux Jeunes Diabétiques (AJD)
  • Association de Langue Française pour l'Etude du Diabète et des Maladies Métaboliques (ALFEDIAM)
  • French National Institute for Health and Medical Research (INSERM)

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (498K)

Cited in:

CrossRef
PubMed Central
Web of Science®(7)

This article has been cited by:

  1. 1
    J. Argente, J.F. Sotos, Hipercrecimientos con y sin obesidad: fundamentos clínicos y moleculares, Anales de Pediatría, 2012, 76, 3, 161.e1

    CrossRef

  2. 2
    Joanna Karbowska, Zdzislaw Kochan, Intermittent fasting up-regulates Fsp27/Cidec gene expression in white adipose tissue, Nutrition, 2012, 28, 3, 294

    CrossRef

  3. 3
    M. E. Visser, E. Kropman, M. E. Kranendonk, A. Koppen, N. Hamers, E. S. Stroes, E. Kalkhoven, H. Monajemi, Characterisation of non-obese diabetic patients with marked insulin resistance identifies a novel familial partial lipodystrophy-associated PPARγ mutation (Y151C), Diabetologia, 2011, 54, 7, 1639

    CrossRef

  4. 4
    J. Gong, Z. Sun, L. Wu, W. Xu, N. Schieber, D. Xu, G. Shui, H. Yang, R. G. Parton, P. Li, Fsp27 promotes lipid droplet growth by lipid exchange and transfer at lipid droplet contact sites, The Journal of Cell Biology, 2011, 195, 6, 953

    CrossRef

  5. 5
    John R. Petrie, Ewan R. Pearson, Calum Sutherland, Implications of genome wide association studies for the understanding of type 2 diabetes pathophysiology, Biochemical Pharmacology, 2011, 81, 4, 471

    CrossRef

  6. 6
    V. E. R. Parker, D. B. Savage, S. O’Rahilly, R. K. Semple, Mechanistic insights into insulin resistance in the genetic era, Diabetic Medicine, 2011, 28, 12
    Direct Link:
  7. 7
    Corinne Vigouroux, Martine Caron-Debarle, Caroline Le Dour, Jocelyne Magré, Jacqueline Capeau, Molecular mechanisms of human lipodystrophies: From adipocyte lipid droplet to oxidative stress and lipotoxicity, The International Journal of Biochemistry & Cell Biology, 2011, 43, 6, 862

    CrossRef

  8. 8
    Sheetal Gandotra, Caroline Le Dour, William Bottomley, Pascale Cervera, Philippe Giral, Yves Reznik, Guillaume Charpentier, Martine Auclair, Marc Delépine, Inês Barroso, Robert K. Semple, Mark Lathrop, Olivier Lascols, Jacqueline Capeau, Stephen O'Rahilly, Jocelyne Magré, David B. Savage, Corinne Vigouroux, Perilipin Deficiency and Autosomal Dominant Partial Lipodystrophy, New England Journal of Medicine, 2011, 364, 8, 740

    CrossRef

  9. 9
    Andrew S. Greenberg, Rosalind A. Coleman, Fredric B. Kraemer, James L. McManaman, Martin S. Obin, Vishwajeet Puri, Qing-Wu Yan, Hideaki Miyoshi, Douglas G. Mashek, The role of lipid droplets in metabolic disease in rodents and humans, Journal of Clinical Investigation, 2011, 121, 6, 2102

    CrossRef

  10. 10
    Tomo Yonezawa, Riho Kurata, Minoru Kimura, Hidetoshi Inoko, Which CIDE are you on? Apoptosis and energy metabolism, Molecular BioSystems, 2011, 7, 1, 91

    CrossRef

  11. 11
    Fanfan Li, Yu Gu, Wenpeng Dong, Hang Li, Liying Zhang, Nanlin Li, Wangzhou Li, Lijun Zhang, Yue Song, Lina Jiang, Jing Ye, Qing Li, Cell death-inducing DFF45-like effector, a lipid droplet-associated protein, might be involved in the differentiation of human adipocytes, FEBS Journal, 2010, 277, 20
    Direct Link:
  12. 12
    Ellen H. Jeninga, Eric Kalkhoven, Central players in inherited lipodystrophies, Trends in Endocrinology & Metabolism, 2010, 21, 10, 581

    CrossRef

  13. 13
    Yasutaka Jinno, Masanori Nakakuki, Ayumi Sato, Hiroyuki Kawano, Tatsuto Notsu, Kiyoshi Mizuguchi, Hitoshi Shimano, Cide-a and Cide-c are induced in the progression of hepatic steatosis and inhibited by eicosapentaenoic acid, Prostaglandins, Leukotrienes and Essential Fatty Acids, 2010, 83, 2, 75

    CrossRef

  14. 14
    Katherine E. Pinnick, Fredrik Karpe, DNA methylation of genes in adipose tissue, Proceedings of the Nutrition Society, 2010, 70, 01, 57

    CrossRef

  15. 15
    Christina G. Fiorenza, Sharon H. Chou, Christos S. Mantzoros, Lipodystrophy: pathophysiology and advances in treatment, Nature Reviews Endocrinology, 2010, 7, 3, 137

    CrossRef

  16. 16
    Justin J. Rochford, Molecular mechanisms controlling human adipose tissue development: insights from monogenic lipodystrophies, Expert Reviews in Molecular Medicine, 2010, 12,

    CrossRef

  17. 17
    C. Vigouroux, What have we learned form monogenic forms of severe insulin resistance associated with PCOS/HAIRAN?, Annales d'Endocrinologie, 2010, 71, 3, 222

    CrossRef

  18. 18
    Stephen O’Rahilly, Human genetics illuminates the paths to metabolic disease, Nature, 2009, 462, 7271, 307

    CrossRef

View Full Article with Supporting Information (HTML) Get PDF (498K)